SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
|
6 Months Ended |
12 Months Ended |
Jun. 30, 2026 |
Dec. 31, 2025 |
| Accounting Policies [Abstract] |
|
|
| SCHEDULE OF FOREIGN CURRENCY TRANSLATION |
For
the six months ended June 30, 2026, the Company used the following exchange rates for its Vietnam subsidiary:
SCHEDULE OF FOREIGN CURRENCY TRANSLATION
| Period ended June 30, 2026 | |
| | | |
|
| Balance sheet,
except for equity accounts | |
₫ | 26,296
| | |
VND to $1 USD |
| Income statement and cash
flows | |
₫ | 26,250
| | |
VND to $1 USD |
| Balance sheet, except for equity accounts | |
| 7.1721 | | |
RMB to $1 USD |
| Income statement and cash flows | |
| 7.2550 | | |
RMB to $1 USD |
|
SCHEDULE
OF FOREIGN CURRENCY TRANSLATION
| Period ended November 30, 2025 | |
| | | |
|
| Balance sheet, except for equity accounts | |
¥ | 7.0751 | | |
RMB to $1 USD |
| Income statement and cash flows | |
¥ | 7.1300 | | |
RMB to $1 USD |
| | |
| | | |
|
| Year ended December 31, 2024 | |
| | | |
|
| Balance sheet, except for equity accounts | |
¥ | 7.2994 | | |
RMB to $1 USD |
| Income statement and cash flows | |
¥ | 7.1887 | | |
RMB to $1 USD |
|
| SCHEDULE OF REVENUE |
SCHEDULE OF REVENUE
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three months ended | | |
Six months ended | |
| | |
June 30, | | |
June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Revenues | |
| | |
| | |
| | |
| |
| Product revenue | |
$ | 157,947 | | |
$ | 749,313 | | |
$ | 259,965 | | |
$ | 1,971,116 | |
| Product revenue - related party | |
| 5,143 | | |
| 146,655 | | |
| 141,691 | | |
| 146,789 | |
| Revenue share - related party | |
| 774,087 | | |
| 501,307 | | |
| 1,720,137 | | |
| 1,071,895 | |
| Total revenues | |
$ | 937,177 | | |
$ | 1,397,275 | | |
$ | 2,121,793 | | |
$ | 3,189,800 | |
|
The
Company generated revenues of $5,980,847 and $10,200,957 for the years ended December 31, 2025 and 2024, respectively.
SCHEDULE
OF REVENUE
| | |
| | | |
| | |
| | |
Years ended | |
| | |
December 31, | |
| | |
2025 | | |
2024 | |
| Revenues | |
| | | |
| | |
| Product revenue | |
$ | 2,346,474 | | |
$ | 7,439,899 | |
| Product revenue - related party | |
| 515,756 | | |
| 6,270 | |
| Revenue share – related party | |
| 2,895,956 | | |
| 2,754,788 | |
| Intelligent Information Service – related party | |
| 222,661 | | |
| - | |
| Total revenues | |
$ | 5,980,847 | | |
$ | 10,200,957 | |
|
| SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED |
Basic
and diluted loss per share were calculated as follows:
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Basic loss per share: | |
| | |
| | |
| | |
| |
| Net loss | |
$ | (175,730 | ) | |
$ | (228,913 | ) | |
$ | (30,129 | ) | |
$ | (306,090 | ) |
| Less: income allocated to participating securities | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
| Net loss allocated to common stockholders | |
$ | (175,730 | ) | |
$ | (228,913 | ) | |
$ | (30,129 | ) | |
$ | (306,090 | ) |
| Weighted-average shares outstanding – basic | |
| 22,600,363 | | |
| 18,000,000 | | |
| 22,598,291 | | |
| 18,000,000 | |
| Loss per share – basic | |
$ | (0.01 | ) | |
$ | (0.01 | ) | |
$ | (0.00 | ) | |
$ | (0.02 | ) |
| Diluted loss per share: | |
| | | |
| | | |
| | | |
| | |
| Net loss | |
$ | (175,730 | ) | |
$ | (228,913 | ) | |
$ | (30,129 | ) | |
$ | (306,090 | ) |
| Weighted-average shares outstanding – diluted | |
| 22,600,363 | | |
| 18,000,000 | | |
| 22,598,291 | | |
| 18,000,000 | |
| Loss per share – diluted | |
$ | (0.01 | ) | |
$ | (0.01 | ) | |
$ | (0.00 | ) | |
$ | (0.02 | ) |
|
|
| SCHEDULE OF PREVIOUSLY REPORTED CONSOLIDATED BALANCE SHEET |
The
effect of the revision on the Company’s previously reported consolidated balance sheet as of December 31, 2025 was as follows:
SCHEDULE OF PREVIOUSLY REPORTED CONSOLIDATED BALANCE SHEET
| | |
As
Previously Reported | | |
Adjustment | | |
As Revised | |
| Accrued and other liabilities | |
$ | 592,822 | | |
$ | 109,022 | | |
$ | 701,844 | |
| Accumulated deficit | |
$ | (27,229,088 | ) | |
$ | (109,022 | ) | |
$ | (27,338,109 | ) |
|
SCHEDULE OF PREVIOUSLY ISSUED CONSOLIDATED
FINANCIAL STATEMENTS
Consolidated
Balance Sheet
| As of December 31, 2025 | |
As Previously Reported | | |
Adjustment | | |
As Restated | |
| Accrued and other liabilities | |
$ | 592,822 | | |
$ | 109,022 | | |
$ | 701,844 | |
| Total current liabilities | |
| 686,821 | | |
| 109,022 | | |
| 795,843 | |
| Total liabilities | |
| 746,384 | | |
| 109,022 | | |
| 855,406 | |
| Accumulated deficit | |
| (27,229,088 | ) | |
| (109,022 | ) | |
| (27,338,110 | ) |
| Total stockholders’ equity | |
| 10,426,202 | | |
| (109,022 | ) | |
| 10,317,180 | |
| Total liabilities and stockholders’ equity | |
$ | 11,172,586 | | |
$ | — | | |
$ | 11,172,586 | |
Consolidated
Statement of Operations and Comprehensive Loss
| Year Ended December 31, 2025 | |
As Previously Reported | | |
Adjustment | | |
As Restated | |
| General and administrative expenses | |
$ | 2,687,250 | | |
$ | 109,022 | | |
$ | 2,796,272 | |
| Total operating expenses | |
| 3,358,314 | | |
| 109,022 | | |
| 3,467,336 | |
| Loss from operations | |
| (505,166 | ) | |
| (109,022 | ) | |
| (614,188 | ) |
| Net loss | |
| (24,817,342 | ) | |
| (109,022 | ) | |
| (24,926,364 | ) |
| Total comprehensive loss | |
$ | (24,817,342 | ) | |
$ | (109,022 | ) | |
$ | (24,926,364 | ) |
Consolidated
Statement of Changes in Stockholders’ Equity
| Year Ended December 31, 2025 | |
As Previously Reported | | |
Adjustment | | |
As Restated | |
| Net loss | |
$ | (24,817,342 | ) | |
$ | (109,022 | ) | |
$ | (24,926,364 | ) |
| Accumulated deficit, December 31, 2025 | |
| (27,229,088 | ) | |
| (109,022 | ) | |
| (27,338,110 | ) |
| Total stockholders’ equity, December 31, 2025 | |
$ | 10,426,202 | | |
$ | (109,022 | ) | |
$ | 10,317,180 | |
Consolidated
Statement of Cash Flows
| Year Ended December 31, 2025 | |
As Previously Reported | | |
Adjustment | | |
As Restated | |
| Net loss | |
$ | (24,817,342 | ) | |
$ | (109,022 | ) | |
$ | (24,926,364 | ) |
| Accrued and other liabilities | |
| 373,007 | | |
| 109,022 | | |
| 482,029 | |
| Net cash used in operating activities | |
$ | (5,555,840 | ) | |
$ | — | | |
$ | (5,555,840 | ) |
|
| SCHEDULE OF ROLL FORWARD OF LEVEL 3 FINANCIAL LIABILITIES (PIPE WARRANT LIABILITY) |
|
The
following table presents a roll forward of the Company’s Level 3 financial liabilities (PIPE Warrant liability) for the year ended
December 31, 2025:
SCHEDULE OF ROLL FORWARD OF LEVEL 3 FINANCIAL LIABILITIES (PIPE WARRANT LIABILITY)
| Description | |
Amount ($) | |
| Beginning balance, January 1, 2025 | |
| - | |
| Initial recognition at Closing Date (December 9, 2025) | |
| 13,798,400 | |
| Change in fair value of PIPE Warrant liability (December 30, 2025) | |
| 16,759,729 | |
| Reclassification to equity (December 30, 2025) | |
| (30,558,129 | ) |
| Ending balance, December 31, 2025 | |
| - | |
|